Equity Overview
Price & Market Data
Price: $0.776
Daily Change: +$0.126 / 16.20%
Range: $0.776 - $0.776
Market Cap: $4,707,391
Volume: 155
Performance Metrics
1 Week: -2.58%
1 Month: -1.02%
3 Months: -22.87%
6 Months: -11.09%
1 Year: 88.93%
YTD: 11.13%
Company Details
Employees: 8
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate is MIE-101 which is based on cowpea mosaic virus which is non-infectious in humans and animals. The company was founded in 2020 and is based in Novato, California.